(Q80603253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

2 January 2020

main subject

1 reference

Andrea Manca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Nigel Rice

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Mark J Sculpher

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Andrew H Briggs

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

471-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

2 January 2020

cites work

1 reference

7 January 2021

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

1 reference

7 January 2021

Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation

1 reference

7 January 2021

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

7 January 2021

Representing uncertainty: the role of cost-effectiveness acceptability curves

1 reference

7 January 2021

Effects of teaching on hospital costs

1 reference

7 January 2021

Issues in the cross-national assessment of health technology

1 reference

7 January 2021

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

1 reference

7 January 2021

Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study

1 reference

7 January 2021

Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation

1 reference

7 January 2021

The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure

1 reference

7 January 2021

Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial

1 reference

7 January 2021

Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial.

1 reference

7 January 2021

The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.

1 reference

7 January 2021

Centre-specific or average unit costs in multi-centre studies? Some theory and simulation

1 reference

7 January 2021

Estimating country-specific cost-effectiveness from multinational clinical trials

1 reference

7 January 2021

Assessing the appropriateness of combining economic data from multinational clinical trials

1 reference

7 January 2021

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

7 January 2021

Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.

1 reference

7 January 2021

Multilevel models: applications to health data.

1 reference

7 January 2021

Multilevel models and health economics

1 reference

7 January 2021

An economic approach to clinical trial design and research priority-setting

1 reference

7 January 2021

A note on confidence intervals in cost-effectiveness analysis

1 reference

7 January 2021

A Bayesian approach to stochastic cost-effectiveness analysis.

1 reference

7 January 2021

The implications of variation in outcome between health professionals for the design and analysis of randomized controlled trials.

1 reference

7 January 2021

A comparison between traditional methods and multilevel regression for the analysis of multicenter intervention studies

1 reference

7 January 2021

Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial

1 reference

7 January 2021

The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15386662%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference